718-1254

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2013-07-10

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate APPLICATION SITE DISCOLOURATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day 35.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day 35.0); relationship: PROBABLE

moderate assessed

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 4.0); relationship: NONE

mild assessed

Mild ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-25 (study day 16.0); relationship: NONE

mild assessed

Mild ARTHRALGIA — outcome: RECOVERED/RESOLVED; onset 2013-07-25 (study day 16.0); relationship: NONE

moderate assessed

Moderate DYSPHAGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 114.0); relationship: not assessed

moderate assessed

Moderate FOOD CRAVING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 114.0); relationship: not assessed

moderate assessed

Moderate SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-03 (study day 56.0); relationship: REMOTE

moderate assessed

Moderate SOMNOLENCE — outcome: RECOVERED/RESOLVED; onset 2013-09-03 (study day 56.0); relationship: REMOTE

Data queries

No data queries.